These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30066228)

  • 21. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
    Cua IH; Hui JM; Kench JG; George J
    Hepatology; 2008 Sep; 48(3):723-31. PubMed ID: 18688878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].
    Hui JM; Sud A; Farrell GC; Bandara P; Byth K; Kench JG; McCaughan GW; George J
    Gastroenterology; 2003 Dec; 125(6):1695-704. PubMed ID: 14724822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.
    Jian Wu Y; Shu Chen L; Gui Qiang W
    Liver Int; 2006 Mar; 26(2):166-72. PubMed ID: 16448454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
    Grigorescu M; Radu C; Crişan D; Grigorescu MD; Serban A; Neculoiu D; Rusu M; Acalovschi M
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):147-54. PubMed ID: 18568135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.
    Köroğlu E; Canbakan B; Atay K; Hatemi İ; Tuncer M; Dobrucalı A; Sonsuz A; Gültepe I; Şentürk H
    Turk J Gastroenterol; 2016 Jul; 27(4):361-6. PubMed ID: 27458852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil to lymphocyte ratio as a reliable marker to predict insulin resistance and fibrosis stage in chronic hepatitis C virus infection.
    Abdel-Razik A; Mousa N; Besheer TA; Eissa M; Elhelaly R; Arafa M; El-Wakeel N; Eldars W
    Acta Gastroenterol Belg; 2015 Dec; 78(4):386-92. PubMed ID: 26712048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
    Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherogenic cytokines and chemokines in chronic hepatitis C are not associated with the presence of cardiovascular diseases.
    Santos TPS; Pereira MM; Schinoni MI; Sampaio GP; Aras R; Atta MLS; Atta AM
    Cytokine; 2019 Mar; 115():24-31. PubMed ID: 30771700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey.
    Aksu HS; Kurtaran B; Onlen Y; Namiduru M; Inkaya AC; Kandemir O; Doran F; Evirgen O; Alpay Y; Tekin SK; Kurekci Y; Unlu B; Midikli D; Taşova Y; Ozdener F; Erdogan S
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1393-9. PubMed ID: 23114743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic steatosis and insulin resistance: does etiology make a difference?
    Lonardo A; Lombardini S; Scaglioni F; Carulli L; Ricchi M; Ganazzi D; Adinolfi LE; Ruggiero G; Carulli N; Loria P
    J Hepatol; 2006 Jan; 44(1):190-6. PubMed ID: 16168516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.
    Vidali M; Occhino G; Ivaldi A; Rigamonti C; Sartori M; Albano E
    Am J Gastroenterol; 2008 Jan; 103(1):147-53. PubMed ID: 18184121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response.
    Crisan D; Grigorescu MD; Radu C; Suciu A; Grigorescu M
    Indian J Med Res; 2017 Apr; 145(4):543-550. PubMed ID: 28862188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.
    Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
    Hepatology; 2008 Jul; 48(1):80-7. PubMed ID: 18571785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.
    Oliveira LP; de Jesus RP; Boulhosa RS; Mendes CM; Gnoatto MC; Lemaire DC; Toralles MB; Cavalcante LN; Lyra AC; Lyra LG
    World J Gastroenterol; 2012 May; 18(18):2203-11. PubMed ID: 22611313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype.
    Oliveira AC; Parise ER; Catarino RM; Lanzoni V; Leite-Mor MM; Simon KA; Junqueira VB
    Free Radic Res; 2009 Dec; 43(12):1187-94. PubMed ID: 19905981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance in chronic hepatitis B and C.
    Mohammad Alizadeh AH; Fallahian F; Alavian SM; Ranjbar M; Hedayati M; Rahimi F; Khedmat H; Etemadi A; Zali MR; Azizi F
    Indian J Gastroenterol; 2006; 25(6):286-9. PubMed ID: 17264427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.